BENEFITS OF REACHING TARGET DOSE
WHY TYVASO?
SO
your patients could see a greater impact after reaching higher doses2
Exercise capacity
Patients receiving a higher dose of TYVASO achieved a 67% greater improvement in 6MWD at 16 weeks2
Hodges-Lehmann analysis.
In the MMRM analysis, patients achieving 10-12 breaths had nearly double the improvement in 6MWD at 16 weeks. Change in 6MWD by dose was a prespecified subgroup analysis.3
The clinical worsening data is a post hoc analysis of data from a prespecified efficacy endpoint. Interpret with appropriate caution.
Clinical worsening
Fewer patients in the higher-dose group experienced a clinical worsening event4*
Percentage of patients experiencing an event.
Encourage your patients to achieve their highest optimal dose.1,2
6MWD=6-minute walk distance; MMRM=mixed-effect model repeat measurement.
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.